In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sloning BioTechnology GmbH

Division of MorphoSys AG
www.sloning.de

Latest From Sloning BioTechnology GmbH

Profitable MorphoSys Proves Value of Technology Partnership Model

A milestone payment from long-time partner Novartis helped German antibody company MorphoSys report record revenues, supporting a 23% increase in R&D spend without the need to tap investors.

BioPharmaceutical Europe

Recent Dealmaking (06/2003)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • MorphoSys AG
  • Senior Management
  • Octavian Schatz, PhD, CEO
    Ulrich Ofer , CFO
    Robert Hofmeister, PhD, Head, Bus. Dev.
    Heinz Schwer, PhD, Head, R&D
  • Contact Info
  • Sloning BioTechnology GmbH
    Phone: (49) 8980 90950
    Zeppelinstrasse 4
    Puchheim, 82178
    Germany
UsernamePublicRestriction

Register